Formation Mechanism of Coamorphous Drug-Amino Acid Mixtures

被引:77
作者
Jensen, Katrine Tarp [1 ]
Larsen, Flemming Hofmann [2 ]
Cornett, Claus [1 ]
Lobmann, Korbinian [1 ]
Grohganz, Holger [1 ]
Rades, Thomas [1 ]
机构
[1] Univ Copenhagen, Dept Pharm, DK-2100 Copenhagen, Denmark
[2] Univ Copenhagen, Dept Food Sci, DK-2100 Copenhagen, Denmark
关键词
coamorphous; amorphization; furosemide; indomethacin; drug-amino acid; SOLID-STATE NMR; DISSOLUTION RATE; AMORPHOUS INDOMETHACIN; PHYSICAL STABILITY; BINARY-SYSTEMS; SOLUBILITY; FUROSEMIDE; FORMS; SPECTROSCOPY; DISPERSIONS;
D O I
10.1021/acs.molpharmaceut.5b00295
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Two coamorphous drug amino add systems, indomethacin tryptophan (Ind-Trp) and furosemide tryptophan (Fur-Trp), were analyzed toward their ease of amorphization and mechanism of coamorphization during ball milling. The two mixtures were compared to the corresponding amorphization of the pure drug without amino acid. Powder blends at a 1:1 molar ratio were milled for varying times, and their physicochemical properties were investigated using XRPD, C-13 solid state NMR (ssNMR), and DSC. Comilling the drug with the amino acid reduced the milling time required to obtain an amorphous powder from more than 90 min in the case of the pure drugs to 30 min for the coamorphous powders. Amorphization was observed as reductions in XRPD reflections and was additionally quantified based on normalized principal component analysis (PCA) scores of the ssNMR spectra. Furthermore, the evolution in the glass temperature (T-g) of the coamorphous systems over time indicated complete coamorphization after 30 min of milling. Based on the DSC data it was possible to identify the formation mechanism of the two coamorphous systems. The T-g position of the samples suggested that coamorphous Ind-Trp was formed by the amino acid being dissolved in the amorphous drug, whereas coamorphous Fur-Trp was formed by the drug being dissolved in the amorphous amino acid.
引用
收藏
页码:2484 / 2492
页数:9
相关论文
共 36 条
[1]   Enhanced dissolution rate and synchronized release of drugs in binary systems through formulation: Amorphous naproxen-cimetidine mixtures prepared by mechanical activation [J].
Alleso, Morten ;
Chieng, Norman ;
Rehder, Soenke ;
Rantanen, Jukka ;
Rades, Thomas ;
Aaltonen, Jaakko .
JOURNAL OF CONTROLLED RELEASE, 2009, 136 (01) :45-53
[2]   HETERONUCLEAR DECOUPLING IN ROTATING SOLIDS [J].
BENNETT, AE ;
RIENSTRA, CM ;
AUGER, M ;
LAKSHMI, KV ;
GRIFFIN, RG .
JOURNAL OF CHEMICAL PHYSICS, 1995, 103 (16) :6951-6958
[3]   Solid-state NMR spectroscopy in pharmaceutical research and analysis [J].
Berendt, Robert T. ;
Sperger, Diana M. ;
Isbester, Paul K. ;
Munson, Eric J. .
TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2006, 25 (10) :977-984
[4]   Prediction of intestinal drug absorption properties by three-dimensional solubility parameters [J].
Breitkreutz, J .
PHARMACEUTICAL RESEARCH, 1998, 15 (09) :1370-1375
[5]   Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation [J].
Chieng, Norman ;
Aaltonen, Jaakko ;
Saville, Dorothy ;
Rades, Thomas .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2009, 71 (01) :47-54
[6]  
Davis T., 2004, SPECTROSC EUR, V13, P20
[7]   FRUSEMIDE CRYSTAL FORMS - SOLID-STATE AND PHYSICOCHEMICAL ANALYSES [J].
DOHERTY, C ;
YORK, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 47 (1-3) :141-155
[8]   Single-crystal investigation of L-tryptophan with Z′=16 [J].
Gorbitz, Carl Henrik ;
Tornroos, Karl Wilhelm ;
Day, Graeme M. .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS, 2012, 68 :549-557
[9]   Novel furosemide cocrystals and selection of high solubility drug forms [J].
Goud, N. Rajesh ;
Gangavaram, Swarupa ;
Suresh, Kuthuru ;
Pal, Sharmistha ;
Manjunatha, Sulur G. ;
Nambiar, Sudhir ;
Nangia, Ashwini .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (02) :664-680
[10]   Solubility parameters as predictors of miscibility in solid dispersions [J].
Greenhalgh, DJ ;
Williams, AC ;
Timmins, P ;
York, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (11) :1182-1190